Characterization of the multiplicity of drug-metabolizing enzymes: observations on cytochrome P-450 diversity

Author(s):  
E. F. Johnson ◽  
M. J. Finlayson ◽  
J. Raucy ◽  
R. H. Tukey
1977 ◽  
Vol 55 (1) ◽  
pp. 34-41 ◽  
Author(s):  
Jean-Gil Joly ◽  
Claude Hétu

The effect of chronic ethanol administration on the hepatic microsomal cytochrome P-450 content and activities of NADPH – cytochrome P-450 reductase (EC 1.6.2.4), benzphetamine demethylase, aniline hydroxylase (EC 1.14.14.1), and of the microsomal ethanol-oxidizing system were studied in various dietary models. When ethanol was given with linoleate as the only source of dietary lipid, the ethanol induction of these parameters was greater with diets containing 2 or 5% of total calories as linoleate than with diets containing 10% of total calories as linoleate. By contrast, when ethanol was given with high fat (35% of total calories) diets, the ethanol induction of these same parameters was slightly greater when linoleate provided 10% of total calories than when it provided 3% of calories. The apparent effect of dietary linoleate on the induction, by ethanol, of microsomal drug-metabolizing enzymes is markedly different when linoleate is given as the only source of dietary lipid as opposed to when it is given with other dietary lipids. Thus, conclusions on the effect of ethanol on hepatic microsomal drug-biotransformation enzymes, drawn from studies with dietary models in which linoleate provides the only source of dietary lipid, cannot be extended to dietary models of more complex lipid composition. When given as the only source of lipid, 2% of total calories in linoleate appears optimal for basal activity and inductibility, by ethanol, of mixed-function oxidases.


1973 ◽  
Vol 136 (4) ◽  
pp. 885-892 ◽  
Author(s):  
Abdulla A.-B. Badawy ◽  
Myrddin Evans

1. Drugs such as phenobarbitone and phenylbutazone, which increase the concentration of microsomal haem and cytochrome P-450, also increase the saturation of rat liver apo-(tryptophan pyrrolase) with its haem activator, as does the haem precursor 5-aminolaevulinate. 2. At 4h after the administration of the porphyrogens 2-allyl-2-isopropylacetamide, 3,5-diethoxycarbonyl-1,4-dihydrocollidine and griseofulvin, the total pyrrolase activity is increased whereas the haem saturation of the apoenzyme is decreased. This decreased saturation is prevented by pretreatment of the animals with the inhibitor of drug-metabolizing enzymes, SKF 525-A. 3. Pretreatment of rats with the above porphyrogens inhibits the rise in holo-(tryptophan pyrrolase) activity produced by subsequent administration of cortisol, tryptophan and 5-aminolaevulinate with two single exceptions, the possible reasons for which are discussed. 4. At 24h after the administration, in starved rats, of a single daily injection of the above porphyrogens for 1 or 2 days, the holoenzyme activity is significantly increased. 5. It is suggested that the saturation of rat liver apo-(tryptophan pyrrolase) with its haem activator can be modified by treatment known to cause destruction, inhibition of synthesis, increased utilization and enhanced synthesis of liver haem. The possible involvement of the latter phenomenon in the aetiology of mental disorders in some patients with porphyria is discussed.


1982 ◽  
Vol 79 (3) ◽  
pp. 201-205 ◽  
Author(s):  
David R. Bickers ◽  
Hasan Mukhtar ◽  
S.J. Molica ◽  
Madhu A. Pathak

1995 ◽  
Vol 41 (12) ◽  
pp. 1864-1869 ◽  
Author(s):  
N K Spurr ◽  
A C Gough ◽  
F I Chinegwundoh ◽  
C A Smith

Abstract The identification of low-penetrance genes, the polymorphisms of which increase an individual's risk of developing cancer, are likely to be extremely important in the general population. In this report we analyzed two genes involved in detoxification. In a number of loci, we identified polymorphic variation correlating with the expression of the gene product. We analyzed two such loci, the cytochrome P-450 gene CYP2D6 and the N-acetyltransferase 2 (NAT2) genes, in patients with bladder and colon cancer, respectively. We observed no statistically significant associations between the control and cancer populations; however, there was a small increase in heterozygote number in bladder cancer.


1974 ◽  
Vol 52 (1) ◽  
pp. 28-38 ◽  
Author(s):  
G. D. Bellward ◽  
R. G. Morgan ◽  
V. H. Szombathy

An assay procedure for the metabolism of 14C-imipramine in vitro is described. Using female mouse liver as the enzyme source, the conditions of the assay have been determined for the formation of 2-hydroxyimipramine, desmethylimipramine, and imipramine-N-oxide. Demethylation was linear up to a substrate concentration of 120 μg/3.5 ml, N-oxidation was linear up to a concentration of imipramine of 70 μg/3.5 ml, and hydroxylation up to 20 μg/3.5 ml of reaction mixture. Desmethylimipramine competitively inhibited both hydroxylation and demethylation, whereas imipramine-N-oxide had no effect. Pretreatment of mice with norethindrone decreased hydroxylation, and increased demethylation. Cytochrome P-450 was also increased by this progestin; N-oxidation was not changed. The effects of concurrent administration of norethindrone with known inducers or inhibitors of drug metabolism have been determined. From these experiments, it was concluded that the induction of cytochrome P-450 by norethindrone is not responsible for the increased demethylation of imipramine. Rather, it appeared that competitive inhibition of hydroxylation of imipramine by the norethindrone allowed more of the drug to be demethylated.


Sign in / Sign up

Export Citation Format

Share Document